ReviewJournal of neurology2026
Efficacy of rTMS and TBS on the motor symptoms in Parkinson's disease: a network meta-analysis.
Review in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07554833 (Clinical Effects of Accelerated rTMS Targeting Motor Cortex on Motor and Cognitive Function in Parkinson's Disease), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical Effects of Accelerated rTMS Targeting Motor Cortex on Motor and Cognitive Function in Parkinson's Disease: A Prospective Pilot Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveThe effects of theta-burst stimulation (TBS) and repetitive transcranial magnetic stimulation (rTMS) on the motor symptoms in Parkinson's disease (PD) were evaluated using a network meta-analysis (NMA).
methodsStudies (1 January 2003-1 January 2025) from four databases were screened for analyses. A Bayesian NMA model was employed, and the surface under the cumulative ranking curve (SUCRA) was used to predict the efficacy ranking of each intervention. The study protocol was registered on the International Prospective Register of Systematic Reviews platform (Identification number: CRD42025646363).
resultsA total of 28 randomized controlled trials were included. Subgroup analysis showed that multi-session cTBS was significantly superior to single-session cTBS in improving motor symptom. The main analysis (23 studies with multi-session protocols) revealed that, compared with sham stimulation, high-frequency (HF) rTMS-stimulating primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC) and cTBS-stimulating supplementary motor area (SMA) significantly improved global motor function, ranking first and second in SUCRA values, respectively. For specific symptoms, HF + SMA showed the best improvement in Freezing of Gait Questionnaire and time up and go test (SUCRA: 0.774 and 0.982, respectively), low-frequency stimulating SMA ranked first for improving bradykinesia (SUCRA = 0.944), and HF + M1 significantly improved quality of life. All interventions were well tolerated.
conclusionMulti-session TBS protocols are superior to single-session protocols. HF + M1 + DLPFC and cTBS + SMA represent the most promising protocols for improving global motor function in PD. For different motor symptoms, corresponding target-specific stimulation should be prioritized.
Indexed as
Identifiers
41817817What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.